Literature DB >> 33266321

Comparative Transcriptomics Analyses in Livers of Mice, Humans, and Humanized Mice Define Human-Specific Gene Networks.

Chengfei Jiang1, Ping Li1, Xiangbo Ruan1, Yonghe Ma1, Kenji Kawai2, Hiroshi Suemizu3, Haiming Cao1.   

Abstract

Mouse is the most widely used animal model in biomedical research, but it remains unknown what causes the large number of differentially regulated genes between human and mouse livers identified in recent years. In this report, we aim to determine whether these divergent gene regulations are primarily caused by environmental factors or some of them are the result of cell-autonomous differences in gene regulation in human and mouse liver cells. The latter scenario would suggest that many human genes are subject to human-specific regulation and can only be adequately studied in a human or humanized system. To understand the similarity and divergence of gene regulation between human and mouse livers, we performed stepwise comparative analyses in human, mouse, and humanized livers with increased stringency to gradually remove the impact of factors external to liver cells, and used bioinformatics approaches to retrieve gene networks to ascertain the regulated biological processes. We first compared liver gene regulation by fatty liver disease in human and mouse under the condition where the impact of genetic and gender biases was minimized, and identified over 50% of all commonly regulated genes, that exhibit opposite regulation by fatty liver disease in human and mouse. We subsequently performed more stringent comparisons when a single specific transcriptional or post-transcriptional event was modulated in vitro or vivo or in liver-specific humanized mice in which human and mouse hepatocytes colocalize and share a common circulation. Intriguingly and strikingly, the pattern of a high percentage of oppositely regulated genes persists under well-matched conditions, even in the liver of the humanized mouse model, which represents the most closely matched in vivo condition for human and mouse liver cells that is experimentally achievable. Gene network analyses further corroborated the results of oppositely regulated genes and revealed substantial differences in regulated biological processes in human and mouse cells. We also identified a list of regulated lncRNAs that exhibit very limited conservation and could contribute to these differential gene regulations. Our data support that cell-autonomous differences in gene regulation might contribute substantially to the divergent gene regulation between human and mouse livers and there are a significant number of biological processes that are subject to human-specific regulation and need to be carefully considered in the process of mouse to human translation.

Entities:  

Keywords:  humanized mice; liver; nonalcoholic fatty liver disease (NAFLD); nonalcoholic steatohepatitis (NASH)

Mesh:

Substances:

Year:  2020        PMID: 33266321      PMCID: PMC7761003          DOI: 10.3390/cells9122566

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  31 in total

1.  The RNA binding protein HuR influences skeletal muscle metabolic flexibility in rodents and humans.

Authors:  Randall L Mynatt; Robert C Noland; Carrie M Elks; Bolormaa Vandanmagsar; David S Bayless; Allison C Stone; Sujoy Ghosh; Eric Ravussin; Jaycob D Warfel
Journal:  Metabolism       Date:  2019-05-23       Impact factor: 8.694

Review 2.  Role of Estrogens in the Regulation of Liver Lipid Metabolism.

Authors:  Brian T Palmisano; Lin Zhu; John M Stafford
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.

Authors:  Malte P Suppli; Kristoffer T G Rigbolt; Sanne S Veidal; Sara Heebøll; Peter Lykke Eriksen; Mia Demant; Jonatan I Bagger; Jens Christian Nielsen; Denise Oró; Sebastian W Thrane; Asger Lund; Charlotte Strandberg; Merete J Kønig; Tina Vilsbøll; Niels Vrang; Karen L Thomsen; Henning Grønbæk; Jacob Jelsing; Henrik H Hansen; Filip K Knop
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-01-17       Impact factor: 4.052

Review 4.  PPARalpha agonist-induced rodent tumors: modes of action and human relevance.

Authors:  James E Klaunig; Michael A Babich; Karl P Baetcke; Jon C Cook; J Chris Corton; Raymond M David; John G DeLuca; David Y Lai; Richard H McKee; Jeffrey M Peters; Ruth A Roberts; Penelope A Fenner-Crisp
Journal:  Crit Rev Toxicol       Date:  2003       Impact factor: 5.635

5.  Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.

Authors:  Andreas Teufel; Timo Itzel; Wiebke Erhart; Mario Brosch; Xiao Yu Wang; Yong Ook Kim; Witigo von Schönfels; Alexander Herrmann; Stefan Brückner; Felix Stickel; Jean-François Dufour; Triantafyllos Chavakis; Claus Hellerbrand; Rainer Spang; Thorsten Maass; Thomas Becker; Stefan Schreiber; Clemens Schafmayer; Detlef Schuppan; Jochen Hampe
Journal:  Gastroenterology       Date:  2016-06-16       Impact factor: 22.682

6.  Extensive double humanization of both liver and hematopoiesis in FRGN mice.

Authors:  Elizabeth M Wilson; J Bial; Branden Tarlow; G Bial; B Jensen; D L Greiner; M A Brehm; M Grompe
Journal:  Stem Cell Res       Date:  2014-09-06       Impact factor: 2.020

7.  Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human.

Authors:  Maryam Rakhshandehroo; Guido Hooiveld; Michael Müller; Sander Kersten
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

8.  GSVA: gene set variation analysis for microarray and RNA-seq data.

Authors:  Sonja Hänzelmann; Robert Castelo; Justin Guinney
Journal:  BMC Bioinformatics       Date:  2013-01-16       Impact factor: 3.169

9.  ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse.

Authors:  Anason S Halees; Rashad El-Badrawi; Khalid S A Khabar
Journal:  Nucleic Acids Res       Date:  2007-11-04       Impact factor: 16.971

10.  Fialuridine induces acute liver failure in chimeric TK-NOG mice: a model for detecting hepatic drug toxicity prior to human testing.

Authors:  Dan Xu; Toshi Nishimura; Sachiko Nishimura; Haili Zhang; Ming Zheng; Ying-Ying Guo; Marylin Masek; Sara A Michie; Jeffrey Glenn; Gary Peltz
Journal:  PLoS Med       Date:  2014-04-15       Impact factor: 11.069

View more
  6 in total

1.  Enhancer looping protein LDB1 regulates hepatocyte gene expression by cooperating with liver transcription factors.

Authors:  Guoyou Liu; Lei Wang; Jürgen Wess; Ann Dean
Journal:  Nucleic Acids Res       Date:  2022-08-26       Impact factor: 19.160

2.  Aberrant gene expression induced by a high fat diet is linked to H3K9 acetylation in the promoter-proximal region.

Authors:  Núria Morral; Sheng Liu; Abass M Conteh; Xiaona Chu; Yue Wang; X Charlie Dong; Yunlong Liu; Amelia K Linnemann; Jun Wan
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2021-02-06       Impact factor: 4.490

3.  Ethyl 2-[2,3,4-Trimethoxy-6-(1-Octanoyl)Phenyl] Acetate (TMPA) Ameliorates Lipid Accumulation by Disturbing the Combination of LKB1 with Nur77 and Activating the AMPK Pathway in HepG2 Cells and Mice Primary Hepatocytes.

Authors:  Xiaoyu Wang; Guangbing Li; Changfa Guo; Jiayao Zhang; Junjie Kong; Jingyi He; Feiyu Li; Yong Liu; Yang Yang; Ziwen Lu; Jun Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-10-02       Impact factor: 3.168

4.  Cathepsin S are involved in human carotid atherosclerotic disease progression, mainly by mediating phagosomes: bioinformatics and in vivo and vitro experiments.

Authors:  Hailong Wang; Xian Wu Cheng; Haiying Jiang
Journal:  PeerJ       Date:  2022-02-08       Impact factor: 2.984

5.  β-Hydroxybutyrate upregulates FGF21 expression through inhibition of histone deacetylases in hepatocytes.

Authors:  Aili Yan; Yanyan Zhao; Lijun Zhang; Xiangyan Liang; Xiaochun Zhang; Fenli Liang; Shen Nian; Xinhua Li; Zhuo Sun; Ke Li; Yu-Feng Zhao
Journal:  Open Life Sci       Date:  2022-08-10       Impact factor: 1.311

6.  Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; T Hyötyläinen; T Sinioja; C Boston; H Puckett; J Oliver; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2021-07-10       Impact factor: 4.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.